In addition, many tumor cells, including multiple myeloma [59], over-express the plasma membrane-associated NAD glycohydrolase CD38, which allows for conversion of extracellular NAD to NAM that can then be used as a precursor for new NAD biosynthesis by the tumor [60]. This evidence concerns the gene CD38 and neoplasm.